Exploring Degradation of Intrinsically Disordered Protein Yes-Associated Protein Induced by Proteolysis TArgeting Chimeras
Authors:
- 27 August 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 67 (17) , 15168-15198
Abstract
Yes-associated protein (YAP) is a key oncogene in the Hippo tumor suppression pathway, historically challenging to target due to its intrinsically disordered nature. Leveraging recent advances in high-throughput screening that identified several YAP binders, we employed proteolysis-targeting chimera technology to develop a series of YAP degraders. Utilizing NSC682769, a known YAP binder, linked with VHL ligand 2 or pomalidomide via diverse linkers, we synthesized degraders including YZ-6. This degrader not only recruits the E3 ligase VHL for the rapid and sustained degradation of YAP but also effectively inhibits its nuclear localization, curtailing YAP/TEAD-mediated transcription in cancer cell lines such as NCI-H226 and Huh7. This dual action significantly diminishes YAP's oncogenic activity, contributing to the potent antiproliferative effects observed both in vitro and in a Huh7 xenograft mouse model. These results underscore the potential of PROTAC-mediated YAP degradation as a strategy for treating YAP-driven cancers.Keywords
All Related Versions
Funding Information
- Cancer Center, University of Florida Health
- Bodor Professorship Endowment fund
This publication has 58 references indexed in Scilit:
- Development of VHL-recruiting STING PROTACs that suppress innate immunityCellular and Molecular Life Sciences, 2023
- Targeted protein degradation: A promise for undruggable proteinsCell Chemical Biology, 2021
- Targeting the YAP-TEAD interaction interface for therapeutic intervention in glioblastomaJournal of Neuro-Oncology, 2021
- PROTACs: An Emerging Therapeutic Modality in Precision MedicineCell Chemical Biology, 2020
- Targeting intrinsically disordered proteins involved in cancerCellular and Molecular Life Sciences, 2019
- Targeted protein degradation: elements of PROTAC designCurrent Opinion in Chemical Biology, 2019
- Adaptation of the bound intrinsically disordered protein YAP to mutations at the YAP:TEAD interfaceProtein Science, 2018
- Molecular Features of the YAP Inhibitor Verteporfin: Synthesis of Hexasubstituted Dipyrrins as Potential Inhibitors of YAP/TAZ, the Downstream Effectors of the Hippo PathwayChemMedChem, 2017
- CCN1/CYR61: the very model of a modern matricellular proteinCellular and Molecular Life Sciences, 2011
- The Hippo Signaling Pathway in Development and CancerDevelopmental Cell, 2010